-
A Breakthrough in Hepatitis B: AusperBio Reports Sustained Functional Cure
A New Milestone in Chronic Hepatitis B Research In a significant development for global health, AusperBio has announced encouraging results from its clinical studies regarding chronic hepatitis B (CHB). The company reported that patients have maintained a sustained functional cure for up to 15 months after stopping all antiviral treatment. Understanding the Clinical Results The…